These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions. Fogh K; Herlin T; Kragballe K J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417 [TBL] [Abstract][Full Text] [Related]
6. Lipoxygenase products of arachidonic acid in human inflamed skin. Black AK; Barr RM; Wong E; Brain S; Greaves MW; Dickinson R; Shroot B; Hensby CN Br J Clin Pharmacol; 1985 Sep; 20(3):185-90. PubMed ID: 2994700 [TBL] [Abstract][Full Text] [Related]
7. Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis. Barr RM; Wong E; Cunningham FM; Mallet AI; Greaves MW Arch Dermatol Res; 1989; 280(8):474-6. PubMed ID: 2537608 [TBL] [Abstract][Full Text] [Related]
8. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products. Cunningham FM; Wong E; Woollard PM; Greaves MW Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241 [TBL] [Abstract][Full Text] [Related]
9. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. Grabbe J; Czarnetzki BM; Rosenbach T; Mardin M J Invest Dermatol; 1984 May; 82(5):477-9. PubMed ID: 6096449 [TBL] [Abstract][Full Text] [Related]
10. Reduction of lipoxygenase products in psoriatic skin homogenates by QA 208-199. Schnyder J; Hunziker T; Strasser M; Richardson B; Krebs A Arch Dermatol Res; 1986; 278(6):494-6. PubMed ID: 3024587 [No Abstract] [Full Text] [Related]
11. Conversion of linoleic acid and arachidonic acid by skin epidermal lipoxygenases. Nugteren DH; Kivits GA Biochim Biophys Acta; 1987 Sep; 921(1):135-41. PubMed ID: 3113487 [TBL] [Abstract][Full Text] [Related]
12. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model. Fogh K; Iversen L; Herlin T; Kragballe K Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin. Dowd PM; Black AK; Woollard PW; Greaves MW Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751 [TBL] [Abstract][Full Text] [Related]
15. Changes in lipoxygenase products from synovial fluid in carrageenan induced arthritis in dogs. Herlin T; Fogh K; Ewald H; Hansen ES; Knudsen VE; Holm I; Kragballe K; Bunger C APMIS; 1988 Jul; 96(7):601-4. PubMed ID: 2841956 [TBL] [Abstract][Full Text] [Related]
16. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. Williams JD; Lee TH; Lewis RA; Austen F J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947 [TBL] [Abstract][Full Text] [Related]
17. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin. Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710 [TBL] [Abstract][Full Text] [Related]